Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aline Risson

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Nature Biomedical Engineering|December 10, 2025
Trispecific engager overcomes tumoural immunosuppressive environmentFernando Aranda, Aline Risson, Pedro Berraondo
Frontiers in Immunology|June 17, 2024
Unveiling the multifaceted antitumor effects of interleukin 33Leire Arrizabalaga, Aline Risson, Miriam Ezcurra-Hualde, et al.
International Review of Cell and Molecular Biology|May 20, 2026
Engineering interleukin-10 for therapeutic applicationsYufei Zheng, Román García-Fuentes, Aline Risson, et al.
International Review of Cell and Molecular Biology|July 23, 2025
Dichotomy of IL-27 in tumor immunityAline Risson, Leire Arrizabalaga, Miriam Ezcurra-Hualde, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 22, 2025
Multicolor Flow Cytometry for Immune Characterization of Omental Metastasis in Peritoneal Carcinomatosis Mice ModelsLeire Arrizabalaga, Ángela Bella, Claudia Augusta Di Trani, et al.
Methods in Cell Biology|March 31, 2024
Peritoneal carcinomatosis in mouse modelsLeire Arrizabalaga, Claudia Augusta Di Trani, Aline Risson, et al.
Trends in Cancer|May 27, 2025
Immunocytokines and cytokine neutralization for cancer immunotherapyPedro Berraondo, Raquel Cuesta, Fernando Aranda, et al.
Oncoimmunology|June 24, 2025
The long-lasting expression of recombinant artLCMV following intraperitoneal administration exerts potent antitumor effects on tumor models of peritoneal carcinomatosisCelia Gomar, Aline Risson, Leire Arrizabalaga, et al.
Theranostics|January 29, 2026
Autocrine activity of engineered IL-33 mRNA enhances adoptive T-cell therapy for peritoneal carcinomatosis and synergizes with IL-12 mRNALeire Arrizabalaga, Claudia Augusta Di Trani, Celia Gomar, et al.
Hematology, Transfusion and Cell Therapy|July 16, 2022
Immune reconstitution after allogenic stem cell transplantation: An observational study in pediatric patientsAline Risson Belinovski, Polliany Dorini Pelegrina, Alberto Cardoso Martins Lima, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Nature Biomedical Engineering|December 10, 2025
Trispecific engager overcomes tumoural immunosuppressive environmentFernando Aranda, Aline Risson, Pedro Berraondo
Frontiers in Immunology|June 17, 2024
Unveiling the multifaceted antitumor effects of interleukin 33Leire Arrizabalaga, Aline Risson, Miriam Ezcurra-Hualde, et al.
International Review of Cell and Molecular Biology|May 20, 2026
Engineering interleukin-10 for therapeutic applicationsYufei Zheng, Román García-Fuentes, Aline Risson, et al.
International Review of Cell and Molecular Biology|July 23, 2025
Dichotomy of IL-27 in tumor immunityAline Risson, Leire Arrizabalaga, Miriam Ezcurra-Hualde, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 22, 2025
Multicolor Flow Cytometry for Immune Characterization of Omental Metastasis in Peritoneal Carcinomatosis Mice ModelsLeire Arrizabalaga, Ángela Bella, Claudia Augusta Di Trani, et al.
Methods in Cell Biology|March 31, 2024
Peritoneal carcinomatosis in mouse modelsLeire Arrizabalaga, Claudia Augusta Di Trani, Aline Risson, et al.
Trends in Cancer|May 27, 2025
Immunocytokines and cytokine neutralization for cancer immunotherapyPedro Berraondo, Raquel Cuesta, Fernando Aranda, et al.
Oncoimmunology|June 24, 2025
The long-lasting expression of recombinant artLCMV following intraperitoneal administration exerts potent antitumor effects on tumor models of peritoneal carcinomatosisCelia Gomar, Aline Risson, Leire Arrizabalaga, et al.
Theranostics|January 29, 2026
Autocrine activity of engineered IL-33 mRNA enhances adoptive T-cell therapy for peritoneal carcinomatosis and synergizes with IL-12 mRNALeire Arrizabalaga, Claudia Augusta Di Trani, Celia Gomar, et al.
Hematology, Transfusion and Cell Therapy|July 16, 2022
Immune reconstitution after allogenic stem cell transplantation: An observational study in pediatric patientsAline Risson Belinovski, Polliany Dorini Pelegrina, Alberto Cardoso Martins Lima, et al.
Pageof 2